These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7562528)

  • 1. Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cells.
    Belcheva MM; Gucker S; Chuang DM; Clark WG; Jefcoat LB; McHale RJ; Toth G; Borsodi A; Coscia CJ
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1513-23. PubMed ID: 7562528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-induced desensitization and down-regulation of delta opioid receptors alter the levels of their 125I-beta-endorphin cross-linked products in subcellular fractions from NG108-15 cells.
    Belcheva MM; Ignatova EG; Young EC; Coscia CJ
    Biochemistry; 1996 Nov; 35(47):14818-24. PubMed ID: 8942644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation.
    Heiss A; Ammer H; Eisinger DA
    Exp Cell Res; 2009 Jul; 315(12):2115-25. PubMed ID: 19362548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY; Hom DS; Loh HH
    Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenylyl cyclase supersensitivity in opioid-withdrawn NG108-15 hybrid cells requires Gs but is not mediated by the Gsalpha subunit.
    Ammer H; Schulz R
    J Pharmacol Exp Ther; 1998 Aug; 286(2):855-62. PubMed ID: 9694942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    Selley DE; Breivogel CS; Childers SR
    Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C.
    Pei G; Kieffer BL; Lefkowitz RJ; Freedman NJ
    Mol Pharmacol; 1995 Aug; 48(2):173-7. PubMed ID: 7651349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
    Prather PL; Loh HH; Law PY
    Mol Pharmacol; 1994 May; 45(5):997-1003. PubMed ID: 8190115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
    Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F
    J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
    Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR
    Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel opioid binding sites associated with nuclei of NG108-15 neurohybrid cells.
    Belcheva M; Barg J; Rowinski J; Clark WG; Gloeckner CA; Ho A; Gao XM; Chuang DM; Coscia C
    J Neurosci; 1993 Jan; 13(1):104-14. PubMed ID: 8423466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse agonistic effect of ICI-174,864 on the cloned delta-opioid receptor: role of G protein and adenylyl cyclase activation.
    Chiu TT; Yung LY; Wong YH
    Mol Pharmacol; 1996 Dec; 50(6):1651-7. PubMed ID: 8967989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.
    Allouche S; Polastron J; Hasbi A; Homburger V; Jauzac P
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):71-8. PubMed ID: 10432302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells.
    Bergsbaken CL; Sommers SL; Law PY
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1474-83. PubMed ID: 7680718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist Activity of the delta-antagonists TIPP and TIPP-psi in cellular models expressing endogenous or transfected delta-opioid receptors.
    Martin NA; Terruso MT; Prather PL
    J Pharmacol Exp Ther; 2001 Jul; 298(1):240-8. PubMed ID: 11408548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term inverse-agonist treatment induces reciprocal changes in delta-opioid agonist and inverse-agonist binding capacity.
    Piñeyro G; Azzi M; De Léan A; Schiller P; Bouvier M
    Mol Pharmacol; 2001 Oct; 60(4):816-27. PubMed ID: 11562445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.